Data/hora: 04/06/2024 03:52:06

Provedor de dados: 	55	
País: 	Brazil	
Título: 	Is Visceral Leishmaniasis the same in HIV-coinfected adults?	
Autores: 	Henn,Guilherme Alves de Lima; Ramos Júnior,Alberto Novaes; Colares,Jeová Keny Baima; Mendes,Lorena Pinho; Silveira,João Gabriel Colares; Lima,Anderson Alberto Façanha; Aires,Bárbara Pontes; Façanha,Mônica Cardoso.	
Data: 	2018-03-01	
Ano: 	2018	
Palavras-chave: 	Leishmaniasis; HIV; Coinfection.	
Resumo: 	ABSTRACT  Introduction: Visceral Leishmaniasis is the most severe form of disease caused by the Leishmania donovani complex, with significant morbidity and mortality in developing countries. Worse outcomes occur among HIV-positive individuals coinfected with Leishmania. It is unclear, however, if there are significant differences on presentation between Visceral Leishmaniasis patients with or without HIV coinfection.  Methods: We reviewed medical records from adult patients with Visceral Leishmaniasis treated at a reference healthcare center in Fortaleza – Ceará, Brazil, from July 2010 to December 2013. Data from HIV-coinfected patients have been abstracted and compared to non-HIV controls diagnosed with Visceral Leishmaniasis in the same period.  Results: Eighty one HIV-infected patients and 365 controls were enrolled. The diagnosis in HIV patients took significantly longer, with higher recurrence and death rates. Kala-azar's classical triad (fever, constitutional symptoms and splenomegaly) was less frequently observed in Visceral Leishmaniasis-HIV patients, as well as jaundice and edema, while diarrhea was more frequent. Laboratory features included lower levels of hemoglobin, lymphocyte counts and liver enzymes, as well as higher counts of blood platelets and eosinophils. HIV-infected patients were diagnosed mainly through amastigote detection on bone marrow aspirates and treated more often with amphotericin B formulations, whereas in controls, rK39 was the main diagnostic tool and pentavalent antimony was primarily used for treatment.  Conclusions: Clinical and laboratory presentation of Visceral Leishmaniasis in HIV-coinfected patients may differ from classic kala-azar, and these differences may be, in part, responsible for the delay in diagnosing and treating leishmaniasis, which might lead to worse outcomes.	
Tipo: 	Info:eu-repo/semantics/article	
Idioma: 	Inglês	
Identificador: 	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000200092	
Editor: 	Brazilian Society of Infectious Diseases	
Relação: 	10.1016/j.bjid.2018.03.001	
Formato: 	text/html	
Fonte: 	Brazilian Journal of Infectious Diseases  v.22 n.2 2018	
Fonte: 	info:eu-repo/semantics/openAccess